Kestrel Labs Inc

Boulder, CO · Medtech · Acquired

Noninvasive pulse oximeter device that continuously measures total hemoglobin and oxygen saturation

kestrellabs.com →
Grants
$997K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
5
0 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Noninvasive Total Hemoglobin Monitor$347,031
Federal grantDepartment of Health and Human Services · Phase I · Pulse Oximeter Innovation to Measure Pulsus Paradoxus and Respiratory Disease Severity$150,000
Federal grantDepartment of Health and Human Services · Phase II · Enhancing the Commercialization Readiness of a Noninvasive Total Hemoglobin Monitor$499,642
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
10442nd Skull, Inc.—$3.0M
1045PhotoniCare, Inc.—$19M
1046Stryd, Inc.—$505K
1047Kestrel Labs Inc——
1048KATHAROS, INC.——
1049BIOSIGHT, LLC——
1050INFORMUTA, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 5
  • User replaceable optical subsystem for laser-based photoplethysmographyapplication
  • Homogenizing Light Sources In Photoplethysmographyapplication
  • Anti-reflective Launch Optics In Laser-based Photoplethysmographyapplication
  • Non-reflective Optical Connections In Laser-based Photoplethysmographyapplication
  • High-throughput Alignment-insensitive Optical Connector For Laser-based Photoplethysmographyapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.